Tag: Market
Epigenetic drugs witness 375% growth in series A venture financing in...
GlobalData’s Pharma Intelligence Center Deals Database reveals that companies developing epigenetic drugs received over $1 billion in total series A venture financing from 2019 to 2024YTD
China’s surge in antibody-drug conjugates positions it as key oncology market,...
ADCs have become a focal point in oncology due to their ability to selectively target cancer cells, resulting in reduced off-target side effects.
Revenues of Indian pharma companies likely to expand by 9-11% in...
Revenues estimated to increase by 9-11% from the US market, and 7-9% each from the European and the domestic markets in FY2025
CSIR-CDRI Lucknow and Zydus to develop best-in-class drug for CKD induced...
Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets
India dominates global turmeric market with 70% of world exports: Study
ICRIER’s Study to Position India as a Global Hub for Turmeric Production and Export
FACE TO FACE: Kishan Karunakaran, Chief Executive Officer, Buyofuel
Kishan Karunakaran, Founder and Chief Executive Officer, Buyofuel, shares his exclusive insights into the India's unique online biofuel marketplace and a key player in the bioenergy sector
C-CAMP enters into strategic collaboration with Indegene to help life science...
The goal of the partnership is to leverage C-CAMP’s incubation program to strengthen the life sciences innovation ecosystem in India and help bring new drugs/therapies to market faster
Chemiluminescence analyzers market in India to grow at 6% CAGR through...
Agappe and Fujirebio are set to launch the analyzers and reagents in June 2024 after significant progress
“There are inconstancies across biosimilar classes right now”
Thomas Newcomer, VP, Head of US Market Access, Samsung Bioepis shares insightful perspectives on the US and Indian biosimilar markets
Strong performance in US market to support growth of Indian pharma...
The projected revenue growth in FY2024 will be primarily supported by 11-13% expansion in the US market and 7-9% growth in the domestic market